Compare TIL & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TIL | DUOT |
|---|---|---|
| Founded | 2018 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.1M | 180.9M |
| IPO Year | 2021 | N/A |
| Metric | TIL | DUOT |
|---|---|---|
| Price | $11.32 | $10.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $100.67 | $12.75 |
| AVG Volume (30 Days) | 73.2K | ★ 287.1K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $19,026,308.00 |
| Revenue This Year | N/A | $292.26 |
| Revenue Next Year | N/A | $43.21 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 159.00 |
| 52 Week Low | $10.70 | $3.84 |
| 52 Week High | $42.79 | $11.23 |
| Indicator | TIL | DUOT |
|---|---|---|
| Relative Strength Index (RSI) | 38.95 | 55.89 |
| Support Level | $10.76 | $9.54 |
| Resistance Level | $11.51 | $11.20 |
| Average True Range (ATR) | 0.88 | 0.59 |
| MACD | 0.15 | 0.02 |
| Stochastic Oscillator | 24.64 | 64.84 |
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.